Dr. Robert Giugliano presents "Results from ANTHEM: A Phase 2 Heparin Replacement
Trial Evaluating rNAPc2 in ACS" at ACC 2007.
Sponsorship for the booth and interviews at ACC 2007 was provided by the Center for Health
Education (CHE) through unrestricted joint educational grants from the Medicines Company,
Merck, Schering-Plough and Scios.
[ Download video ] |
|